XML 21 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Unaudited Consolidated Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Loss, Net of Tax
Non-controlling Interests In Consolidated Subsidiary
Balance (in shares) at Dec. 31, 2022   320.3          
Balance (in shares) at Dec. 31, 2022         (4.2)    
Balance at beginning of period at Dec. 31, 2022 $ 9,686.8 $ 3.2 $ 2,843.2 $ 7,356.3 $ (504.6) $ (12.1) $ 0.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 383.9     383.9      
Other comprehensive income 2.8         2.8  
Cash dividends declared (156.5)     (156.5)      
Issuances of common stock (in shares)   0.3     0.1    
Issuances of common stock (11.0)   2.9   $ (13.9)    
Stock-based compensation 11.3   12.3 (1.0)      
Balance (in shares) at Mar. 31, 2023   320.6          
Balance (in shares) at Mar. 31, 2023         (4.3)    
Balance at end of period at Mar. 31, 2023 $ 9,917.3 $ 3.2 2,858.4 7,582.7 $ (518.5) (9.3) 0.8
Balance (in shares) at Dec. 31, 2023   320.7          
Balance (in shares) at Dec. 31, 2023 (6.1)       (6.1)    
Balance at beginning of period at Dec. 31, 2023 $ 10,543.5 $ 3.2 2,900.8 8,433.9 $ (783.5) (12.1) 1.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 453.7     453.8     (0.1)
Other comprehensive income 6.8         6.8  
Cash dividends declared (168.5)     (168.5)      
Issuances of common stock (in shares)   0.5     0.2    
Issuances of common stock (25.3)   3.2   $ (28.5)    
Stock-based compensation 10.7   12.0 (1.3)      
Distributions paid $ (0.3)           (0.3)
Balance (in shares) at Mar. 31, 2024   321.2          
Balance (in shares) at Mar. 31, 2024 (6.3)       (6.3)    
Balance at end of period at Mar. 31, 2024 $ 10,820.6 $ 3.2 $ 2,916.0 $ 8,717.9 $ (812.0) $ (5.3) $ 0.8